Interacting Drugs |
Doxepin (systemic) vs NSAID (COX-2 Inhibitor) |
Security Level |
 |
Mechanism |
NSAID (COX-2 Inhibitor): Antidepressants (Tricyclic, Tertiary Amine) may enhance the antiplatelet effect of NSAID (COX-2 Inhibitor). |
Management |
Monitor therapy |
Doxepin (systemic) vs NSAID (COX-2 Inhibitor)
Post Review about Doxepin (systemic) vs NSAID (COX-2 Inhibitor) Click here to cancel reply.
Other Interactions of Doxepin (systemic)
Other Interactions of NSAID (COX-2 Inhibitor)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.